ArticleFASEB bioAdvances2025

Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine.

Yu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.